Columbia Sportswear Company (COLM) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Q4 2024 net sales rose 3% year-over-year to $1.1 billion, led by strong EMEA (+24%) and LAAP (+7%) growth, while US declined 1% and Canada was flat.
Operating margin expanded to 12.5% (+180 bps), aided by non-recurrence of prAna impairment and gross margin gains, partially offset by higher SG&A.
Full-year 2024 net sales declined 3% to $3.37 billion, with U.S. wholesale weakness offsetting 1% global DTC growth; diluted EPS fell 7% to $3.82.
Inventory decreased 7% year-over-year; cash and equivalents ended at $815.5 million with no borrowings.
Profit improvement program delivered $90 million in cost savings; $318 million in share repurchases and $70 million in dividends returned to shareholders.
Financial highlights
Q4 gross margin expanded 50 bps to 51.1% due to lower inventory clearance and favorable input costs, partially offset by FX headwinds.
Q4 operating income grew 21% to $137.3 million; net income up 10% to $102.6 million; diluted EPS up 16% to $1.80.
SG&A expenses rose 6% in Q4, mainly from higher incentive compensation and DTC costs.
Full-year gross margin up 60 bps to 50.2%; operating margin for the year was 8.0% (down 90 bps); free cash flow for 2024 was $431.2 million.
Year-end cash and equivalents: $815.5 million; inventories down 7% to $690.5 million.
Outlook and guidance
2025 net sales expected at $3.40–$3.47 billion, up 1–3% year-over-year; gross margin projected to expand 80 bps to ~51%.
SG&A as a percent of sales to rise to 43.4–44.1%; operating margin projected at 7.7–8.3%.
Diluted EPS guidance: $3.80–$4.15, including a $0.30 FX headwind; operating cash flow at least $250 million; capex $60–$80 million.
Q1 2025 net sales expected to decline 1–3% year-over-year; EPS $0.62–$0.70.
Demand creation spend to rise to 6.5% of sales in 2025 (from 5.9% in 2024).
Latest events from Columbia Sportswear Company
- Q2 sales dropped 8% as U.S. weakness offset gains abroad, but cash and inventory improved.COLM
Q2 20248 Jul 2026 - Q1 sales up 1%, outlook withdrawn amid tariff uncertainty; strong cash, share buybacks.COLM
Q1 20258 Jul 2026 - Board elections, key proposals, and 2025 results highlighted modest growth and strategic shifts.COLM
AGM 202615 Jun 2026 - Q1 2026 sales held steady at $779M as innovation and digital growth drive long-term strategy.COLM
Investor presentation15 May 2026 - Flat Q1 sales, improved FY2026 outlook, and strong international growth offset U.S. softness.COLM
Q1 20267 May 2026 - 2025 delivered modest sales growth, strong global expansion, and robust financial discipline.COLM
Investor presentation30 Apr 2026 - 2026 annual meeting covers director elections, pay, stock plan, and proxy access, with Board opposition to proxy access.COLM
Proxy filing24 Apr 2026 - Key votes include board elections, auditor ratification, and a proxy access proposal.COLM
Proxy filing24 Apr 2026 - Q4 sales fell 2% but margin rose; 2026 outlook sees 1–3% growth and tariff pressure.COLM
Q4 20254 Feb 2026